Squalane Market to Grow at a 6.98% CAGR Through 2032, Driven by Rising Cosmetics Demand

Squalane Market: Strategic Intelligence for 2026 — Executive Brief from PW Consulting

Executive summary

As demand for high-purity emollients intensifies across cosmetics, pharmaceuticals and nutraceuticals, the global squalane market is moving from a niche raw material market into a strategically important supply chain node. PW Consulting’s Squalane Market report (base year 2025; historical coverage 2020–2025; forecast 2026–2032) models this transition and projects continued expansion at a compound annual growth rate (CAGR) of 6.98% across the forecast window. Our top-level model shows the market scaling materially from its 2025 base, reflecting rising per-unit demand from premium personal-care formulas, reformulations driven by sustainability, and new downstream adoption in adjacent therapeutic and supplement segments.
Squalane Market

Why this matters for corporate decision-makers in 2026

Capital allocation: Accurate demand-growth visibility for 2026–2032 lets C-suite teams prioritize fermentation capacity, long-term feedstock contracts, or integration into finished-goods portfolios.
Supply strategy: The market’s current concentration metrics indicate a fragmented supply side, creating windows for vertically integrated players and agile niche suppliers to capture share through reliability and traceability.
Regulatory alignment: New regulatory and trade constraints materially change the risk profile of marine-derived supply; cosmetic brands and ingredient brokers need immediate audit and compliance strategies.
Innovation prioritization: With fermentation and plant-based routes closing the cost and scale gap with legacy marine sources, R&D and procurement must coordinate to accelerate qualification of sustainable grades.

Market sizing and trajectory — a data-driven snapshot

PW Consulting’s consolidated market sizing establishes 2025 as the analytical base year. From a clearly defined starting point in 2025, our forecast model (2026–2032) integrates demand momentum, feedstock volatility, and regulatory shifts to produce a robust outlook. Across the forecast horizon, the market is expected to grow at roughly 7% CAGR, illustrating both steady demand and episodic shifts driven by supply-side events. The model’s scenario suite quantifies upside from accelerated adoption of biotechnology-derived grades and downside under protracted feedstock disruptions.
Squalane Market

Market structure and competitive intensity

The Squalane Market remains relatively decentralized. Our concentration analysis shows the three-largest suppliers control just under one quarter of the market, and the five-largest account for a modest incremental share beyond that — a signal that supply remains accessible to new entrants, contract manufacturers and vertically integrated producers alike. This fragmentation creates tactical openings for medium-sized specialty chemical firms and biotechnology players to scale rapidly through selective capacity investments, offtake agreements with cosmetic leaders, and technology licensing.
Squalane Market

Dynamics shaping supply and demand

Regulatory shocks: In mature regulatory jurisdictions there has been a clear shift away from certain marine-derived sources in cosmetics. Recent restrictions and tighter CITES enforcement have accelerated brand-level delisting of some legacy raw materials and elevated the importance of supplier traceability.
Raw-material volatility: Climate effects in key Mediterranean producing areas during 2023–2024 disrupted olive yields, increasing feedstock price volatility and shortening supplier planning horizons. PW Consulting estimates short-term climate-linked supply-chain headwinds have exerted measurable negative pressure on availability during the historical window.
Biotech parity and scale: Fermentation-derived and other biosynthetic production routes have reached economic parity with several legacy sources at cosmetic grade, enabling rapid scaling by industrial biotech firms. This parity changes bargaining dynamics between buyers and suppliers and reduces a structurally embedded price premium for “natural” labels.
Downstream demand dynamics: Cosmetics continue to be the largest single application driver, supported by premiumization, clean-beauty positioning and multi-functional formulation trends. Pharmaceuticals and food-supplement use cases are smaller but deliver differentiated margin profiles and longer contract tenors.

Competitive landscape — strategic moves to watch

We profile the market’s active players and recent strategic actions to help commercial and corporate development teams build scenario-based responses.

Amyris, Inc. (Emeryville, CA) — Known for sugarcane-derived fermentation-based squalane, Amyris expanded fermentation capacity in 2025 to serve major cosmetics customers, emphasizing scalable biosynthetic supply chains. (https://amyris.com/)
Sophim SAS (Peyruis, France) — A strategic acquisition in 2025 broadened Sophim’s plant-derived footprint, combining traditional olive-derived grades with newer fermentation-based ingredients to appeal to sustainability-conscious formulators. (https://www.sophim.com/en/)
Henry Lamotte Oils GmbH (Bremen, Germany) — Specialist in high-purity natural squalane from vegetable and marine sources, focusing on quality differentiation for cosmetic and industrial users. (https://lamotte-oils.de/en/)
Kishimoto Special Liver Oil Co., Ltd. (Tokyo, Japan) — Longstanding supplier of shark-liver squalane and related ingredients; regulatory shifts have required rapid portfolio adaptation and market repositioning. (https://www.kslo.co.jp/)
Empresa Figueirense de Pesca, Lda (Figueira da Foz, Portugal) — Producer of high-purity squalene and squalane from marine and olive sources with a focus on specialty cosmetic grades. (https://efp.pt/)
Croda International Plc (Watford, UK) — A major specialty-ingredient house advancing both biosynthetic and plant-based squalane offerings, integrating technical support and formulation services for brand partners. (https://www.croda.com/)
Evonik Industries AG (Essen, Germany) — Targeting pharmaceutical and cosmetic applications with plant-based alternatives and formulation know-how. (https://corporate.evonik.com/)
Kuraray Co., Ltd. (Tokyo, Japan) — Developer of synthetic squalane grades with applications spanning personal care and certain industrial use cases. (https://www.kuraray.com/)

Recent strategic developments (selected)

Amyris completed a notable fermentation capacity expansion in 2025 to meet rising contract volumes from major cosmetic brands.
Sophim strengthened its plant-sourced position through a targeted acquisition that expands olive-derived production capability and geographic reach.
New fermentation-derived product launches in early 2025 signaled increased market availability of lower-carbon squalane grades from specialist biotech start-ups.

Report contents — what PW Consulting delivers

Our Squalane Market report is intentionally practical and structured for corporate users making decisions in 2026. Key deliverables include:

Comprehensive market-size model (2020–2032) with base-year 2025 calibration and scenario toggles for feedstock disruption, rapid biotech adoption, and regulatory tightening.
Supply-chain heat maps and supplier capability matrices to help procurement prioritize qualification pathways and dual-sourcing approaches.
Regulatory and compliance playbook outlining audits, certification pathways and documentation required across major jurisdictions.
Competitive benchmarking with technology-readiness and capacity overlays — enabling rapid identification of potential partners, acquisition targets and contract-manufacturing options.
Commercial contract templates, offtake negotiation levers and an ROI tool for capacity investments and vertical integration.
Scenario-based risk matrices tying climate, regulatory and geopolitical events to operational KPIs and P&L sensitivities.

How to use this intelligence in 2026 — five prioritized actions

Lock in medium-term supply through layered contracts: Combine short-term flexible purchases with longer-term offtake or capacity reservations to manage volatility without overcommitting capital.
Accelerate qualification of biosynthetic grades: With biotechnology routes reaching commercial parity, formulators should fast-track compatibility testing and marketing claims verification.
Audit and remediate traceability gaps: Compliance-driven delistings have shown that brands without robust provenance controls face rapid product disruption; remediation is high-return.
Pursue selective M&A or JV plays: Given fragmented concentration metrics, disciplined consolidation or strategic partnerships can deliver scale and margin improvement for mid-market players.
Embed climate risk into sourcing models: Short-term yield shocks in key feedstock geographies require dynamic sourcing plans and stress-tested inventory policies.

Why PW Consulting’s report is the right tool

Our analysis combines proprietary industry surveys, supplier primary interviews, and a deterministic demand model built from product-level formulation data. The report balances executive-ready strategic recommendations with granular operational tools — but, in keeping with our “trailer” approach, the public summary deliberately withholds certain granular regional, type and application splits. Those detailed segmentations, supplier-by-supplier volumes and downloadable data tables are available exclusively via the full report download and accompanying data license.

Next steps and access

For commercial teams, procurement leads and corporate development groups preparing strategic plans for 2026, PW Consulting’s Squalane Market report provides immediately actionable intelligence. To access the full dataset, detailed segmentation, supplier scorecards and the scenario model used to produce the 6.98% CAGR outlook, please visit the PW Consulting research portal or contact our industry team to schedule a briefing.

Authorized excerpt: PW Consulting — Squalane Market, 2026 edition. Base year: 2025; Historical period: 2020–2025; Forecast period: 2026–2032.

For detailed analysis of this topic, please visit the official page:Squalane Market

Lacy Lee
Senior Marketing Manager
sales@pmarketresearch.com
00852-95632430
PW Consulting: www.pmarketresearch.com